Gene therapy safety study for inherited high triglycerides and pancreatitis
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This Phase 1 trial tests the safety of a gene therapy for people with inherited, hard-to-control high triglycerides (fat in the blood) who have had pancreatitis episodes. It may help by targeting the genes involved in triglyceride control, but the main goal here is to check safety and tolerability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have inherited (genetic) high triglycerides that are not well controlled with usual treatment and diet.
- You have had pancreatitis at least once seriously, or pancreatitis episodes twice, within the last 5 years.
- Your fasting triglyceride level is above a set threshold (and you followed a low-fat diet before the blood test).
- Your genetic test shows a change in the GPIHBP1 or LPL gene (either one can qualify).
- If you can get pregnant, you must use reliable birth control starting before screening and continuing through the study (and for months after).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with acute pancreatitis caused by very high blood fat levels (triglycerides). It aims to collect information to better understand and treat this condition.
This study tests whether a GLP-1 medication (a drug that helps control blood sugar and triglycerides) can prevent pancreatitis from coming back in people who had a severe attack caused by very high triglyceride levels. If it works, it could help you avoid future painful attacks.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This trial tests a one-time gene therapy (NGGT006) to treat a severe form of inherited high cholesterol that doesn't respond well to standard medications. It aims to lower cholesterol and reduce the risk of heart disease.
This trial tests two experimental drugs, HRS-7249 and SHR-1918, to lower very high triglyceride levels in people who are at high risk for pancreatitis. It aims to see if these drugs can reduce the risk of pancreatitis attacks.
This trial tests a new gene therapy (NGGT006) for people with a genetic form of high cholesterol that doesn't respond to standard treatments. It aims to lower cholesterol levels that remain high despite maximum medication.
Hear when a new Hypertriglyceridemia, Familial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.